News Releases

A clinical article reviewing the long-term performance of the latest structured breast implant technology received the 2019 PRS Best Cosmetic Surgery Paper Award at Plastic Surgery – The Meeting 2019 in San Diego last month. The winning article concludes that…

The Therapeutic Goods Administration (TGA) has today released the findings of its review into breast implants and breast tissue expanders following reports of around 100 cases of Breast Implant Associated Anaplastic Large Cell Lymphoma in Australia, including four deaths. The…

Washington, D.C., July 24, 2019—(FDA) The U.S. Food and Drug Administration today took significant action to protect women from breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) by requesting that Allergan, the manufacturer of a specific type of textured implant, recall…

Washington, D.C., May 02, 2019—(FDA) There has been a growing discussion in recent months around the safety of certain breast implants, with regulatory agencies around the world weighing the risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). It’s an…